In patients with multiple sclerosis (MS), increased frequencies of EBV specific, HLA-E restricted CD8+ T-cells have been found to be associated mostly with the relapsing remitting form of the disease rather than the progressive form [36]. The gene discussed is CD8A; the disease is myeloid sarcoma.